The Journal of Infectious Diseases · 2012 · 16 citations · 15 references
Public HealthInfectious DiseasesMicrobiologyHiv PreventionInfection PreventionVirologyAntiretroviral TherapyHiv EpidemiologyHiv TestingPrevention Of Sexual TransmissionSexually Transmitted InfectionsViral InfectionsHiv InfectiousnessHiv Prevention In WomenHiv Seroconversion PreventionHiv Transmission DynamicsHuman Immunodeficiency Virus TransmissionSingle-cell Genome SequencingTenofovir TherapyVaginal Microbicides
Alterations of the genital mucosal barrier may influence the number of viruses transmitted from a human immunodeficiency virus-infected source host to the newly infected individual. We used heteroduplex tracking assay and single-genome sequencing to investigate the effect of a tenofovir-based microbicide gel on the transmission bottleneck in women who seroconverted during the CAPRISA 004 microbicide trial. Seventy-seven percent (17 of 22; 95% confidence interval [CI], 56%-90%) of women in the tenofovir gel arm were infected with a single virus compared with 92% (13 of 14; 95% CI, 67%->99%) in the placebo arm (P = .37). Tenofovir gel had no discernable impact on the transmission bottleneck.
15
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0
Koichiro Tamura, Joel T. Dudley, M Nei et al. · Molecular Biology and Evolution · 2007 · 28.8K citations · Full text
Brandon F. Keele, Elena E. Giorgi, Jesus F. Salazar-Gonzalez et al. · Proceedings of the National Academy of Sciences · 2008 · 1.9K citations · Full text
Life Sciences, Evolutionary Biology, Infectious Diseases +17